Soft‐tissue sarcomas (STS) are rare tumors that account for 1% of all adult malignancies,
with over 100 different histologic subtypes occurring predominately in the trunk, extremity …

Soft tissue sarcomas (STS) are rare solid tumors of mesenchymal cell origin that display a
heterogenous mix of clinical and pathologic characteristics. STS can develop from fat …

Soft tissue sarcomas (STS) are rare malignancies of mesenchymal cell origin that display a
heterogenous mix of clinical and pathologic characteristics. STS can develop from fat …

Soft tissue sarcomas (STS) are rare solid tumors of mesenchymal cell origin that display a
heterogenous mix of clinical and pathologic characteristics. STS can develop from fat …

Soft-tissue sarcomas have traditionally been managed by wide excisional surgery and
radiotherapy, with chemotherapy reserved for advanced disease. However, advances in …

Soft tissue sarcoma (STS) is an extremely heterogeneous group of rare tumors that share a
putative mesenchymal cell origin. STS can occur in any soft tissue in the body, yet all share …

Soft-tissue sarcomas (STS) are relatively uncommon, especially when considered as
individual histological subtypes (of which there are more than 50). Their incidence increases …

Background Data suggest that the current American Joint Committee on Cancer (AJCC) soft
tissue sarcoma (STS) staging criteria merit further evaluation. We sought to identify and …

Soft-tissue sarcoma (STS) is a rare and heterogeneous group of tumours that comprise
approximately 1% of all adult cancers, and encompass over 50 different subtypes. These …

Background Managing soft-tissue sarcoma (STS) relies on histologic grade, which is the
strongest prognostic factor and a routine assessment at biopsy. However, underestimation of …